This excerpt taken from the SYT 6-K filed Feb 8, 2007.
Crop Protection: The business outperformed a challenging market due to the strength of its portfolio and the ongoing success of its marketing strategy. New products continued to expand with sales up 25 percent to $985 million driven by the successful launches of AXIAL® and AVICTA® and by continuing growth in CALLISTO® and ACTARA®/CRUISER®. In NAFTA sales were higher after a strong second half performance. In EAME, growth in Eastern Europe and in Africa and the Middle East offset lower sales in Western Europe. In Latin America growth was achieved despite reduced soybean acreage in Brazil, as the broad product range and effective risk management led to further market share gain. Asia Pacific increased sales in a number of markets, notably China, India and South East Asia. Sales of
This excerpt taken from the SYT 20-F filed Mar 1, 2006.
The Crop Protection segment principally manufactures, distributes and sells herbicides, insecticides and fungicides to both agricultural and non-agricultural customers. In the opinion of Syngenta, very few of the required segmental disclosures can be disaggregated accurately into separate agricultural and non-agricultural segments at present, sales being the major exception. Several different industry sectors are represented within Syngentas non-agricultural customer base for professional products.
This excerpt taken from the SYT 6-K filed Feb 14, 2006.
Crop Protection: New products continued to expand with sales up 22 percent* to $847 million driven by the CALLISTO® range ($387 million) and ACTARA®/CRUISER® ($346 million). In NAFTA sales grew across all product lines. Sales in Europe also improved in the fourth quarter after a cold early season followed by drought in southern Europe; Eastern Europe maintained its record of double-digit growth. In Latin America, an improvement in the second half in Brazil and a strong performance in Argentina resulted in modest growth for the full year. Asia-Pacific increased sales in a number of markets, notably China and Japan. The new product range will be augmented by eight new active ingredients targeted for launch by 2012 which have a combined peak sales potential of around $1 billion. The first of these products, the cereal herbicide AXIAL® and seed treatment AVICTA® will be launched for the 2006 season. EBITDA in Crop Protection increased by one percent (CER) to $1513 million, with sales growth and cost savings more than offsetting the impact of higher oil price related costs and increased marketing expenditure.
This excerpt taken from the SYT 6-K filed Jul 28, 2005.
Crop Protection: NAFTA delivered an excellent broad-based performance with growth across the region. Asia-Pacific increased sales in several markets, notably Japan. Sales in Europe were weaker largely attributable to the cold early season followed by drought in southern Europe, notably Spain; growth in eastern Europe was again strong. Compared with an exceptional 2004 in Latin America, the strengthening Brazilian currency was the major contributor to a deceleration in demand by growers for export. New products continued their outstanding growth record with sales up 20 percent (CER) to $572 million. EBITDA increased by five percent (CER) to $1318 million.
This excerpt taken from the SYT 20-F filed Mar 16, 2005.
This excerpt taken from the SYT 6-K filed Feb 15, 2005.
Crop Protection: Sales increased across all product lines and in all regions, with Europe and Latin America generating the strongest growth. Increased disease pressure, notably from soybean rust in Latin America and septoria resistance in European cereals, contributed to a double-digit increase in fungicide sales, with AMISTAR® exceeding $500 million. Insecticides benefited from the roll-out of new combination products while solid growth in herbicides demonstrated the strength of this product line. Professional Products continued a record of top line growth driven largely by the expansion of seed treatment. Total sales of new products grew by 32 percent (CER) to reach $688 million with continuing growth in the CALLISTO® range ($289 million) and in ACTARA®/CRUISER® ($298 million) as well as the successful launch of ENVOKE® on cotton in the USA. The range rationalization program reduced sales by $49 million (CER) in 2004. This four year program, with a cumulative sales impact of $301 million, is now complete. EBITDA rose by 22 percent (CER) to $1463 million.
EXCERPTS ON THIS PAGE: